PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

Urological literature review: October 2003 ? October 2004. Part II
Article published in Urologia Polska 2005/58/2.

authors

Andrzej Borkowski, Tomasz Borkowski
Klinika Urologii Akademii Medycznej w Warszawie
Kierownik kliniki: prof. dr hab. Andrzej Borkowski

references

  1. McConnell JD, Roehrborn CG, Bautista OM et al: The long-term effect of doxazosin, finasteride and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003; 349: 2387-2398.
  2. Roehrborn CG, Marks LS, Fenter T et al: Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia. Urology 2004; 63: 709-715.
  3. Debruyne F, Barkin J, van Erps P et al: Efficacy and safety of long-term treatment with dual 5 alfa-reductase inhibitor Dutasteride in men with symptomatic benign prostatic hyperplasia. Eur Urol 2004; 46: 488-495.
  4. Lee JY, Kim HW, Lee SJ et al: Comparison of doxazosin with or without tolterodine in men with symptomatic outlet obstruction and an overactive bladder. BJU International 2004; 94: 817-820.
  5. Thomas AW, Cannon A, Bartlett E et al: The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up. BJU International 2004; 93: 745-750.
  6. Hill B, Belville W, Bruskewitz R et al: Transurethral needle ablation versus transurethral resection of the prostatefor the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 2004; 171: 2336-2340.
  7. Westenberg A, Gilling P, Kennett K et al: Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomised trial with 4-year minimum long-term followup. J Urol 2004; 172: 616-619.
  8. Grise P, Plante M, Martinez-Sagarra J et al: Ewaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a multicenter evaluation. Eur Urol 2004; 46: 496-502.
  9. Berger AP, Wirtenberger W, Bektic J et al: Safer transurethral resection of the prostate: coagulating intermittent cutting reduces hemostatic complications. J Urol 2004; 171: 289-291.
  10. Drury NE, Dyer JP, Breitenfeldt N et al: Management of acute epididymitis: are European guidelines being followed. Eur Urol 2004; 46: 522-525.
  11. Reitz A, Knapp PA, Muntener M et al: A new pharmacological approach to detrusor-sphincter dyssynergia in spinal cord injured patients? Eur Urol 2004; 45: 516-520.
  12. Sairanen J, Forsell T, Ruutu M: Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J Urol 2004; 171: 2138-2141.
  13. Teh-Wei H, Wagner TD, Bentkover JD et al: Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology 2004; 63: 461-465.
  14. Albouy B, Sambius C, Anderou A et al: La bandelette trans-obturatrice pour incontinence urinaire peut-elle exposer a une retention d?urine complete? Progres en Urologie 2004; 14: 189-191.
  15. Bednarek W, Stachowicz N, Maciejczyk-Pencuła M et al: Pre-pubic TVT u kobiet z nietrzymaniem moczu. Opis techniki zabiegu oraz wyniki wstępne. Gin Pol 2004; 75: 615-620.
  16. Leng WW, Davies BJ, Tarin T et al: Delayed treatment of bladder outlet obstruction after sling surgery: association with irrreversible bladder dysfunction. J Urol 2004; 172: 1379-1381.
  17. Hodoroff M, Portis A, Siegel S: Endoscopic removal of intravesical polypropylene sling with holmium laser. J Urol 2004; 72: 1361-1362.
  18. De Laval J: Novel Surgical technique for the treatement of female stress urinary incontinence: transobturator vaginal tape inside-out. Eur Urol 2003; 44: 724-730.
  19. Darcq C, Guy L, Mansoor A et al: Compression de l?urethre bulbaire par bandelette sous uretrale trans-obturatrice: etude anatomique. Prog Urol 2004; 14: 507-511.
  20. Dikranian AH, Chang JH, Rhee EY et al: The male perineal sling: comparison of sling material. J Urol 2004; 172: 608-610.
  21. Rodriguez LV, de Almeida F, Dorey F et al: Does Valsalva leak point pressure predict outcome after distal urethral propylene sling? Role of urodynamics in the sling era. J Urol 2004; 172: 210-214.
  22. Chandi DD, Groenendijk PM, Venema PL: Functional extracorporeal magnetic stimulation as a treatment for female urinary incontinence: ?the chair?. BJU International 2003; 93: 539-542.
  23. Rosen RC: Lower urinary tract symptoms and sexual dysfunction: additional evidence of an association. BJU International 2004; 93: 689-690.
  24. Aversa A, Isidori AM, Greco EA et al: Hormonal supplementation and erectile dysfunction. Eur Urol 2004; 45: 535-538.
  25. Von Keitz A, Rajfer J, Segal S et al: A multicenter, randomised, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil. Eur Urol 2004; 45: 499-509.
  26. Saltzman EA, Guay AT, Jacobson J: Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. J Urol 2004; 172: 255-258.
  27. Waldinger MD, Zwinderman AH, Olivier B: On-demand treatment of premature ejaculation with Clomipramine and Paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment. Eur Urol 2004; 46: 510-516.
  28. Montorsi F, Briganti A, Salonia A et al: Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol 2004; 45: 123-133.
  29. Darewicz JS, Darewicz BA, Gałek LM et al: Surgical treatment of Peyronie?s disease by the intracavernosal plaque excision metod: a New surgical technique. Eur Urol 2004; 45: 77-81.
  30. Van Velthoven R, Peltier A, Laguna MP et al: Laparoscopic extraperitoneal adenomectomy (Milin): pilot study on feasibility. Eur Urol 2004; 45: 103-109.
  31. Shaaban AA, Mosbah A, Abdel-Latif M et al: Outcome of patients with continent urinary reconstruction and a solitary functioning kidney. BJU International 2003; 92: 987-992.
  32. Kessler TM, Burkhard FC, Perimenis P et al: Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol 2004; 172: 1323-1327.
  33. Lovasz S, Nyirady P, Romics I: A new concept for active ureteric occlusion during percutaneous nephrolithotripsy: the ?counter-flow? principle. BJU International 2004; 93: 1355-1356.
  34. Lee DI, Uribe C, Eichel L et al: Sealing percutaneous nephrolithotomy tracts with gelatin matrix hemostatic sealant: the initial clinical use. J Urol 2004; 171: 575-578.
  35. Sheir KZ, Zabihi N, Lee D et al: Evaluation of synchronous twin pulse technique for shock wave lithotripsy: determination of optimal parameters in vitro stone fragmantation. J Urol 2003; 170: 2190-2194.
  36. Dogra PN, Ansari MS, Gupta MP et al: Holmium laser core-through urethrotomy for traumatic obliterative strictures of urethra: initial experirnce. Urology 2004; 64: 232-236.
  37. Hargreave TB, Meuleman EJH, Weidner W: Hormonal replacement therapy for aging men? The debate goes on. Eur Urol 2004; 46: 155-161.
  38. Christ-Crain M, Mueller B, Gasser TC et al: Is there clinical relevance of partial androgen deficiency of the aging male? J Urol 2004; 172: 624-627.
  39. Surange RS, Johnson RWG, Tavakoli A et al: Kidney transplantation into an ileal conduit: a single center experience of 59 cases. J Urol 2003; 170: 1727-1730.
  40. Rashid MG, Konnak JW, Wolf JS et al: Ex vivo ureteroscopic treatement of calculi in donor kidneys at renal transplantation. J Urol 2004; 171: 58-60.
  41. Tash JA, Applegarth LD, Kerr SM et al: Postmortem sperm retrieval: the effect of instituting giudelines. J Urol 2003; 170: 1922-1925.

correspondence

Andrzej Borkowski
Klinika Urologii AM
ul. Lindleya 4
02-005 Warszawa
tel. (022) 502 17 23
urolwa@warman.com.pl